Combination therapy in cachexia
نویسندگان
چکیده
منابع مشابه
Bile acids for cachexia therapy
Dear Editor, In a recent letter [1], Dr. Kapoor commented on our paper describing the effects of ursodeoxycholic acid (UDCA) in a model of severe cancer cachexia [2]. Dr. Kapoor is obviously correct in stating that there is emerging data showing that bile acids such as UDCA may be beneficial in gastrointestinal cancers by attenuating cancer progression. However, in our study, the aim was to cha...
متن کاملNutritional therapy for cancer cachexia.
T he process of inflammation has a paradoxical effect. This is mostly due to the metabolic responses triggered by the release of the three proinflammatory cytokines, interleukin 1b (IL-1b), tumour necrosis factor a (TNF-a), and interleukin 6 (IL-6). As an integral part of the body’s response to infection and injury, these mediators release substrate, from host tissues, to support T and B lympho...
متن کاملMultimodal Therapy for Cancer Cachexia
Understand how the diverse mechanisms of cancer cachexia; mean that a multimodal therapeutic approach is necessary; Understand the need to develop more sensitive/robust outcomes for cachexia therapy; Understand basic assessment of patients with cancer cachexia; Understand the elements that make up a multimodal approach to the management of cancer cachexia; Understand the issues of com...
متن کاملNovel mechanism of ghrelin therapy for cachexia
I read with great interest the recent article by Ji-an Chen et al. Calorie intake is a major factor for the body composition including muscle mass. So, increase of food intake by the ghrelin administration in vivo could be one of the mechanisms for improvement of muscle wasting. In addition to that, this article showed the novel mechanism, which suggested that ghrelin administration could impro...
متن کاملCombination therapy in hypertension.
The goal of antihypertensive therapy is to abolish the risks associated with blood pressure (BP) elevation without adversely affecting quality of life. Drug selection is based on efficacy in lowering BP and in reducing cardiovascular (CV) end points including stroke, myocardial infarction, and heart failure. Although the choice of initial drug therapy exerts some effect on long-term outcomes, i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Palliative Medicine
سال: 2019
ISSN: 2224-5820,2224-5839
DOI: 10.21037/apm.2018.08.05